“invitae” Archives

Entry Author Date Location
Agenda Posted: Xconomy’s Bay Area Life Science Disruptors On Dec. 10 11/19/15 San Francisco
West Coast Bio Roundup: Theranos, 23andMe, Invitae, Gritstone, Etc. 10/23/15 San Francisco
What’s Your DNA Worth? The Scramble To Cash In On the Genome 10/20/15 National
Xconomy Forum: The Bay Area’s Life Science Disruptors 10/08/15 National
West Coast Biotech Roundup: Gilead, Conatus, Exelixis, and More 09/25/15 San Diego
West Coast Biotech Roundup: Global Blood, Invitae, GeneWEAVE, Adynxx 08/13/15 San Francisco
In Tough Diagnostics World, Will Ruling Out Cancer Be Good Business? 08/04/15 National
West Coast Biotech Roundup: Laguna, SeaGen, Unchained, DME & More 02/19/15 San Francisco
West Coast Biotech Roundup: Dendreon, Invitae, Juno, Regulus & More 02/12/15 Seattle
Aiming for One-Stop Diagnostic Tests, Invitae Raises $102M in IPO 02/12/15 San Francisco
Invitae Receives $101,600,000 New Funding Round 02/11/15 San Francisco
West Coast Biotech Roundup: Tobira, Novartis, NantCell, & More 01/15/15 San Francisco
West Coast Biotech Roundup: Illumina, Atara, Invitae, Canaan & More 10/17/14 San Francisco
Invitae Garners $120,000,000 Series F Funding Round 10/13/14 San Francisco
Invitae Receives $120,000,000 Series F Funding 10/13/14 San Francisco
Invitae Secures $40,000,000 Series E Financing Round 12/12/13 San Francisco
SV Bio, Backed by Sequoia, Strives to Make Medical Genomics Simple 01/22/13 San Francisco
InVitae, Led by Randy Scott, Goes ‘All-in’ For Genomic Diagnostics 01/18/13 San Francisco
Page 1 of 1